DrugRepV_7813 | 2-aminobenzoic acid | NA | NA | Severe acute respiratory syndrome coronavirus | NA | NA | Fluorometric assay | Decrease (50 %) | Experimental | 16638531 |
DrugRepV_7818 | 5-Chloro-pyridin-3-yl Furan-2-carboxylate | NA | NA | Severe acute respiratory syndrome coronavirus | NA | NA | Fluorometric assay | Decrease (50 %) | NA | 17381079 |
DrugRepV_7819 | 5-Chloropyridin-3-yl Benzofuran-2-carboxylate | NA | NA | Severe acute respiratory syndrome coronavirus | NA | NA | Fluorometric assay | Decrease (50 %) | NA | 17381079 |
DrugRepV_7820 | 5-Bromo-pyridin-3-yl Furan-2-carboxylate | NA | NA | Severe acute respiratory syndrome coronavirus | NA | NA | Fluorometric assay | Decrease (50 %) | NA | 17381079 |
DrugRepV_7821 | 5-Chloro-pyridin-3-yl-1H-indole-2-carboxylate | NA | NA | Severe acute respiratory syndrome coronavirus | NA | NA | Fluorometric assay | Decrease (50 %) | NA | 17381079 |
DrugRepV_7822 | 5-Chloropyridin-3-yl-benzo-(b)-thiophene-2-carboxylate | NA | NA | Severe acute respiratory syndrome coronavirus | NA | NA | Fluorometric assay | Decrease (50 %) | NA | 17381079 |
DrugRepV_7823 | 5-Chloropyridin-3-yl-thiazole-4-carboxylate | NA | NA | Severe acute respiratory syndrome coronavirus | NA | NA | Fluorometric assay | Decrease (50 %) | NA | 17381079 |
DrugRepV_7824 | 5-Chloropyridin-3-yl-3-methoxybenzoate | NA | NA | Severe acute respiratory syndrome coronavirus | NA | NA | Fluorometric assay | Decrease (50 %) | NA | 17381079 |
DrugRepV_7825 | 5-Chloropyridin-3-yl-5-(4-chlorophenyl)furan-2-carboxylate | NA | NA | Severe acute respiratory syndrome coronavirus | NA | NA | Fluorometric assay | Decrease (50 %) | NA | 17381079 |